Hoya Corp. (OTCMKTS:HOCPY - Get Free Report)'s stock price gapped down prior to trading on Friday . The stock had previously closed at $144.75, but opened at $139.60. Hoya shares last traded at $139.53, with a volume of 2,548 shares traded.
Wall Street Analysts Forecast Growth
Several research firms have weighed in on HOCPY. The Goldman Sachs Group upgraded Hoya from a "hold" rating to a "strong-buy" rating in a report on Wednesday, July 23rd. Nomura Securities upgraded Hoya to a "strong-buy" rating in a report on Monday, August 18th. Three analysts have rated the stock with a Strong Buy rating, According to MarketBeat.com, Hoya currently has an average rating of "Strong Buy".
Get Our Latest Research Report on Hoya
Hoya Trading Up 2.5%
The business's 50 day simple moving average is $131.68 and its 200 day simple moving average is $121.79. The company has a debt-to-equity ratio of 0.03, a current ratio of 5.19 and a quick ratio of 4.46. The stock has a market cap of $49.07 billion, a P/E ratio of 34.89, a PEG ratio of 2.98 and a beta of 0.94.
Hoya (OTCMKTS:HOCPY - Get Free Report) last released its quarterly earnings data on Friday, August 1st. The technology company reported $1.05 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.04 by $0.01. Hoya had a return on equity of 21.01% and a net margin of 23.57%.The firm had revenue of $1.53 billion during the quarter, compared to analyst estimates of $1.47 billion. On average, analysts expect that Hoya Corp. will post 3.66 earnings per share for the current fiscal year.
Hoya Company Profile
(
Get Free Report)
HOYA Corporation, a med-tech company, provides high-tech and medical products worldwide. It operates through three segments: Life Care, Telecommunication, and Other. The company offers life care products, including eyeglass and contact lenses; medical endoscopes; intraocular lenses; laparoscopic surgical instruments; automatic endoscope cleaning equipment; and other medical related products, such as prosthetic ceramic fillers and metallic implants for orthopedics.
Recommended Stories
Before you consider Hoya, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hoya wasn't on the list.
While Hoya currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.